Cargando…

A Rapid Appraisal of Factors Influencing Praziquantel Treatment Compliance in Two Communities Endemic for Schistosomiasis in Côte d’Ivoire

Over the past decade, a significant reduction in the prevalence of schistosomiasis has been achieved, partially explained by the large-scale administration of praziquantel. Yet, the burden of schistosomiasis remains considerable, and factors influencing intervention coverage are important. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Coulibaly, Jean T., Ouattara, Mamadou, Barda, Beatrice, Utzinger, Jürg, N’Goran, Eliézer K., Keiser, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073597/
https://www.ncbi.nlm.nih.gov/pubmed/30274465
http://dx.doi.org/10.3390/tropicalmed3020069
_version_ 1783344227075227648
author Coulibaly, Jean T.
Ouattara, Mamadou
Barda, Beatrice
Utzinger, Jürg
N’Goran, Eliézer K.
Keiser, Jennifer
author_facet Coulibaly, Jean T.
Ouattara, Mamadou
Barda, Beatrice
Utzinger, Jürg
N’Goran, Eliézer K.
Keiser, Jennifer
author_sort Coulibaly, Jean T.
collection PubMed
description Over the past decade, a significant reduction in the prevalence of schistosomiasis has been achieved, partially explained by the large-scale administration of praziquantel. Yet, the burden of schistosomiasis remains considerable, and factors influencing intervention coverage are important. This study aimed to deepen the understanding of low treatment coverage rates observed in two schistosomiasis-endemic villages in Côte d’Ivoire. The research was conducted in August 2015, in Moronou and Bigouin, two villages of Côte d’Ivoire that are endemic for Schistosoma haematobium and S. mansoni, respectively. After completion of a clinical trial, standard praziquantel treatment (single 40 mg/kg oral dose) was offered to all village inhabitants by community health workers using a house-to-house approach. Factors influencing treatment coverage were determined by a questionnaire survey, randomly selecting 405 individuals. The overall treatment coverage rate was only 47.6% (2730/5733) with considerable intervillage heterogeneity (27.7% in Bigouin (302/1091) versus 52.3% in Moronou (2428/4642)). Among the 200 individuals interviewed in Moronou, 50.0% were administered praziquantel, while only 19.5% of the 205 individuals interviewed in Bigouin received praziquantel. The main reasons for low treatment coverage were work-related (agricultural activities), the bitter taste of praziquantel and previous experiences with adverse events. The most suitable period for treatment campaigns was reported to be the dry season. More than three-quarter of the interviewees who had taken praziquantel (overall, 116/140; Moronou, 84/100; Bigouin, 32/40) declared that they would not participate in future treatments (p < 0.001). In order to enhance praziquantel treatment coverage, careful consideration should be given to attitudes and practices, such as prior or perceived adverse events and taste of praziquantel, and appropriate timing, harmonized with agricultural activities. Without such understanding, breaking the transmission of schistosomiasis remains a distant goal.
format Online
Article
Text
id pubmed-6073597
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60735972018-09-24 A Rapid Appraisal of Factors Influencing Praziquantel Treatment Compliance in Two Communities Endemic for Schistosomiasis in Côte d’Ivoire Coulibaly, Jean T. Ouattara, Mamadou Barda, Beatrice Utzinger, Jürg N’Goran, Eliézer K. Keiser, Jennifer Trop Med Infect Dis Article Over the past decade, a significant reduction in the prevalence of schistosomiasis has been achieved, partially explained by the large-scale administration of praziquantel. Yet, the burden of schistosomiasis remains considerable, and factors influencing intervention coverage are important. This study aimed to deepen the understanding of low treatment coverage rates observed in two schistosomiasis-endemic villages in Côte d’Ivoire. The research was conducted in August 2015, in Moronou and Bigouin, two villages of Côte d’Ivoire that are endemic for Schistosoma haematobium and S. mansoni, respectively. After completion of a clinical trial, standard praziquantel treatment (single 40 mg/kg oral dose) was offered to all village inhabitants by community health workers using a house-to-house approach. Factors influencing treatment coverage were determined by a questionnaire survey, randomly selecting 405 individuals. The overall treatment coverage rate was only 47.6% (2730/5733) with considerable intervillage heterogeneity (27.7% in Bigouin (302/1091) versus 52.3% in Moronou (2428/4642)). Among the 200 individuals interviewed in Moronou, 50.0% were administered praziquantel, while only 19.5% of the 205 individuals interviewed in Bigouin received praziquantel. The main reasons for low treatment coverage were work-related (agricultural activities), the bitter taste of praziquantel and previous experiences with adverse events. The most suitable period for treatment campaigns was reported to be the dry season. More than three-quarter of the interviewees who had taken praziquantel (overall, 116/140; Moronou, 84/100; Bigouin, 32/40) declared that they would not participate in future treatments (p < 0.001). In order to enhance praziquantel treatment coverage, careful consideration should be given to attitudes and practices, such as prior or perceived adverse events and taste of praziquantel, and appropriate timing, harmonized with agricultural activities. Without such understanding, breaking the transmission of schistosomiasis remains a distant goal. MDPI 2018-06-19 /pmc/articles/PMC6073597/ /pubmed/30274465 http://dx.doi.org/10.3390/tropicalmed3020069 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Coulibaly, Jean T.
Ouattara, Mamadou
Barda, Beatrice
Utzinger, Jürg
N’Goran, Eliézer K.
Keiser, Jennifer
A Rapid Appraisal of Factors Influencing Praziquantel Treatment Compliance in Two Communities Endemic for Schistosomiasis in Côte d’Ivoire
title A Rapid Appraisal of Factors Influencing Praziquantel Treatment Compliance in Two Communities Endemic for Schistosomiasis in Côte d’Ivoire
title_full A Rapid Appraisal of Factors Influencing Praziquantel Treatment Compliance in Two Communities Endemic for Schistosomiasis in Côte d’Ivoire
title_fullStr A Rapid Appraisal of Factors Influencing Praziquantel Treatment Compliance in Two Communities Endemic for Schistosomiasis in Côte d’Ivoire
title_full_unstemmed A Rapid Appraisal of Factors Influencing Praziquantel Treatment Compliance in Two Communities Endemic for Schistosomiasis in Côte d’Ivoire
title_short A Rapid Appraisal of Factors Influencing Praziquantel Treatment Compliance in Two Communities Endemic for Schistosomiasis in Côte d’Ivoire
title_sort rapid appraisal of factors influencing praziquantel treatment compliance in two communities endemic for schistosomiasis in côte d’ivoire
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073597/
https://www.ncbi.nlm.nih.gov/pubmed/30274465
http://dx.doi.org/10.3390/tropicalmed3020069
work_keys_str_mv AT coulibalyjeant arapidappraisaloffactorsinfluencingpraziquanteltreatmentcomplianceintwocommunitiesendemicforschistosomiasisincotedivoire
AT ouattaramamadou arapidappraisaloffactorsinfluencingpraziquanteltreatmentcomplianceintwocommunitiesendemicforschistosomiasisincotedivoire
AT bardabeatrice arapidappraisaloffactorsinfluencingpraziquanteltreatmentcomplianceintwocommunitiesendemicforschistosomiasisincotedivoire
AT utzingerjurg arapidappraisaloffactorsinfluencingpraziquanteltreatmentcomplianceintwocommunitiesendemicforschistosomiasisincotedivoire
AT ngoraneliezerk arapidappraisaloffactorsinfluencingpraziquanteltreatmentcomplianceintwocommunitiesendemicforschistosomiasisincotedivoire
AT keiserjennifer arapidappraisaloffactorsinfluencingpraziquanteltreatmentcomplianceintwocommunitiesendemicforschistosomiasisincotedivoire
AT coulibalyjeant rapidappraisaloffactorsinfluencingpraziquanteltreatmentcomplianceintwocommunitiesendemicforschistosomiasisincotedivoire
AT ouattaramamadou rapidappraisaloffactorsinfluencingpraziquanteltreatmentcomplianceintwocommunitiesendemicforschistosomiasisincotedivoire
AT bardabeatrice rapidappraisaloffactorsinfluencingpraziquanteltreatmentcomplianceintwocommunitiesendemicforschistosomiasisincotedivoire
AT utzingerjurg rapidappraisaloffactorsinfluencingpraziquanteltreatmentcomplianceintwocommunitiesendemicforschistosomiasisincotedivoire
AT ngoraneliezerk rapidappraisaloffactorsinfluencingpraziquanteltreatmentcomplianceintwocommunitiesendemicforschistosomiasisincotedivoire
AT keiserjennifer rapidappraisaloffactorsinfluencingpraziquanteltreatmentcomplianceintwocommunitiesendemicforschistosomiasisincotedivoire